hotspot -WSS

hotspot

author：explore 2025-09-06 01:58:04 - browse：974

Vertex Pharmaceuticals - sunset — Bill Sikes/AP

LONDON — Regulators in the U.K. on Thursday approved a CRISPR-based medicine to treat both sickle cell disease and beta thalassemia, making it the world’s first therapy built on the revolutionary gene-editing technology and ushering in a new era of genetic medicine.

The authorization of the therapy, from Vertex Pharmaceuticals and CRISPR Therapeutics, is itself not a surprise. Clinical trials have shown the one-time treatment enabled many sickle cell patients to live free of debilitating pain crises and relieved thalassemia patients of needing regular blood transfusions, raising hopes that they have been effectively cured. But it also stands as a major achievement, coming just over a decade after the first and seminal lab experiments that showed CRISPR’s potential as a gene-editing tool were published.

In granting conditional approval to the therapy, which will have the brand name Casgevy and is also known as exa-cel, the U.K.’s Medicines and Healthcare products Regulatory Agency jumped ahead of its counterparts in the U.S. and Europe, which are also reviewing the medicine, in greenlighting the globe’s first CRISPR treatment. The MHRA’s authorization is for patients who are at least 12 years old.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Readout Newsletter: XBI biotech index, Akero Therapeutics

entertainment

explore

WSS

The most pressing bird flu mysteries scientists want answered

Finland to offer bird flu vaccine to select groups of people, a possible global first

Congress needs to close a vaccine

Senate panel to vote on hospitals, PBMs, prisoner care

A new initiative will help leaders fight the next pandemic

Finland to offer bird flu vaccine to select groups of people, a possible global first

hotspot

hotspot

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Medicare Advantage's lean provider networks lead CMS complaints

Affirmative action in medical school literally saved lives

Traditional Chinese medicine benefits explored in new JAMA study

New air purifier tech could be key to improving indoor air quality

Traditional Chinese medicine benefits explored in new JAMA study

Novavax promises a turnaround & Lilly roils the obesity market

FTC loses bid to block Novant's North Carolina hospital merger

Psychedelics group wrestles with new pharma identity

UnitedHealth CEO's Medicaid comments send insurer stocks diving

hotspot

Medicare Advantage's lean provider networks lead CMS complaints

A new initiative will help leaders fight the next pandemic

WHO may add ‘noma' to its list of neglected tropical diseases

The pink breast cancer awareness ribbon needs a redesign

FDA has safety concerns on CRISPR

CDC recommends rationing of RSV shot due to shortages

entertainment

entertainment

explore

hotspot